Eli Lilly
-
November 20, 2020, Friday
WHO advises doctors against using Gilead's remdesivir for treating Covid-19
The recommendation is a blow to Gilead's drug, which was one of the first thought to offer a meaningful benefit to coronavirus ...
-
November 10, 2020, Tuesday
Eli Lilly's Covid-19 antibody drug treatment gets emergency USFDA clearance
The FDA authorised the experimental treatment, called bamlanivimab, for use against mild-to-moderate Covid-19 in adults, ...
-
October 29, 2020, Thursday
Eli Lilly ready to ship 100,000 doses of Covid drug; waiting for FDA nod
The initial agreement is for delivery over the first two months following an emergency authorisation
-
October 14, 2020, Wednesday
Race for coronavirus cure hits reality as clinic complications mount
Regulators and drugmakers have faced questions about whether political pressure was overwhelming scientific rigor ahead of the ...
-
October 14, 2020, Wednesday
Eli Lilly to continue other Covid-19 antibody drug trials after pausing one
Lilly said the government-sponsored clinical trial of its Covid-19 antibody treatment, which is similar to one taken by U.S. ...
-
October 14, 2020, Wednesday
Lilly halts trial of antibody drug Trump touted as cure over safety concern
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his ...
-
August 04, 2020, Tuesday
US drugmaker Eli Lilly starts phase 3 trial for Covid-19 antibody treatment
The first-of-its-kind study is expected to enrol up to 2,400 participants who live or work at facilities that have had a recently ...
-
April 11, 2020, Saturday
Coronavirus: Eli Lilly starts testing; Gilead drug shows positive signs
Lilly said it currently does not anticipate shortages for any of its medicines, including baricitinib
-
January 07, 2019, Monday
Eli Lilly to buy cancer treatment company Loxo Oncology for $8 bn in cash
The cash deal comes on the heels of Bristol-Myers Squibb Co's agreement last week to buy Celgene Corp for $74 billion in the ...
-
October 11, 2018, Thursday
Eli Lilly plans expansion, looks to grow presence in Indian market
Eli plans to bring some of its molecules from the global pipeline to India, especially in the oncology and diabetes space
